These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8825703

  • 21. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo AA, Alameri HF, Akbar HO, Bzeizi KI.
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [Abstract] [Full Text] [Related]

  • 22. Association between HLA class II antigens and hepatitis C virus infection.
    Scotto G, Fazio V, D'Alessandro G, Monno L, Saracino A, Palumbo E, Angarano G.
    J Biol Regul Homeost Agents; 2003 Aug; 17(4):316-21. PubMed ID: 15065760
    [Abstract] [Full Text] [Related]

  • 23. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH, Xu XY, Tian GS, Yu YY.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548
    [Abstract] [Full Text] [Related]

  • 24. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 14; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 25. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C.
    Mochizuki K, Hayashi N, Katayama K, Hiramatsu N, Kanto T, Mita E, Tatsumi T, Kuzushita N, Kasahara A, Fusamoto H, Yokochi T, Kamada T.
    Hepatology; 1997 Mar 14; 25(3):713-8. PubMed ID: 9049224
    [Abstract] [Full Text] [Related]

  • 26. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.
    Med Sci Monit; 2000 Mar 14; 6(5):964-70. PubMed ID: 11208439
    [Abstract] [Full Text] [Related]

  • 27. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
    Shiffman ML, Stewart CA, Hofmann CM, Contos MJ, Luketic VA, Sterling RK, Sanyal AJ.
    J Infect Dis; 2000 Dec 14; 182(6):1595-601. PubMed ID: 11069229
    [Abstract] [Full Text] [Related]

  • 28. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR, Suzuki T, Aizaky H, Flichman D, Colombatto P, Abate ML, Oliveri F, Matsuura Y, Bonino F, Miyamura T.
    Ital J Gastroenterol; 1996 Dec 14; 28(9):499-504. PubMed ID: 9131394
    [Abstract] [Full Text] [Related]

  • 29. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR.
    J Clin Virol; 2006 Mar 14; 35(3):298-302. PubMed ID: 16290052
    [Abstract] [Full Text] [Related]

  • 30. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S.
    Gastroenterology; 2008 May 14; 134(5):1376-84. PubMed ID: 18471514
    [Abstract] [Full Text] [Related]

  • 31. Complexity of the HVR-1 quasispecies and disease activity in patients with hepatitis C.
    Kumagai N, Kaneko F, Tsunematsu S, Tsuchimoto K, Tada S, Saito H, Hibi T.
    Eur J Clin Invest; 2007 Jul 14; 37(7):566-72. PubMed ID: 17576208
    [Abstract] [Full Text] [Related]

  • 32. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Pérez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D.
    J Med Virol; 1997 Jun 14; 52(2):219-25. PubMed ID: 9179772
    [Abstract] [Full Text] [Related]

  • 33. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML.
    Am J Gastroenterol; 1999 Dec 14; 94(12):3576-82. PubMed ID: 10606322
    [Abstract] [Full Text] [Related]

  • 34. Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage.
    Carabaich A, Ruvoletto M, Bernardinello E, Tono N, Cavalletto L, Chemello L, Gatta A, Pontisso P.
    J Med Virol; 2005 May 14; 76(1):55-60. PubMed ID: 15778969
    [Abstract] [Full Text] [Related]

  • 35. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T, Makiyama A, Nakayama M, Sumida Y, Mitsuyoshi H, Nakajima T, Yasui K, Minami M, Itoh Y.
    J Hepatol; 2005 Oct 14; 43(4):599-605. PubMed ID: 16024129
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
    Bruce MG, Bruden D, McMahon BJ, Christensen C, Homan C, Sullivan D, Deubner H, Hennessy T, Williams J, Livingston S, Gretch D.
    Liver Int; 2006 Aug 14; 26(6):643-9. PubMed ID: 16842319
    [Abstract] [Full Text] [Related]

  • 37. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
    Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P.
    Hepatology; 2002 Nov 14; 36(5):1285-91. PubMed ID: 12395342
    [Abstract] [Full Text] [Related]

  • 38. Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis.
    Marcos Y, Fainboim HA, Capucchio M, Findor J, Daruich J, Reyes B, Pando M, Theiler GC, Méndez N, Satz ML.
    Hepatology; 1994 Jun 14; 19(6):1371-4. PubMed ID: 8188167
    [Abstract] [Full Text] [Related]

  • 39. Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences.
    Honda M, Kaneko S, Unoura M, Kobayashi K, Murakami S.
    Hepatology; 1993 Jun 14; 17(6):971-6. PubMed ID: 8390397
    [Abstract] [Full Text] [Related]

  • 40. [Immunohistochemical analysis of HLA class I antigens of the hepatocyte membrane in hepatitis B virus carriers].
    Hou JL, Lou KX, Zhang L.
    Zhonghua Nei Ke Za Zhi; 1990 Jan 14; 29(1):29-31, 61. PubMed ID: 2205450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.